Skip to content
Home
about
Team
Approach
Portfolio
Impact
News
contact
Investor Portal
Home
about
Team
Approach
Portfolio
Impact
News
contact
Investor Portal
Neohla
Back to portfolio
Targeted depletion of newly identified disease-driving T cell subsets
Status:
Stealth
Location:
UK and Belgium
Board director:
Roderick Verhelst - Tom Heyman
Related news
No related news at the moment